Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targeted drug to patients ...
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, treatment options after chemotherapy fails have been essentially nonexistent ...
Program Countdown straps time-bombs to each player, forcing them to hunt for time extenders as they complete Trials. If the time runs out, the entire team dies a fiery death, resulting in a failed ...
The FDA has initiated a pilot program for real-time clinical trials, partnering with AstraZeneca and Amgen to test oncology therapies while streaming safety and efficacy data directly to regulators.
Clinical trials are essential for testing the effectiveness of promising new therapies to improve the lives of people with neurofibromatosis. Many people living with NF are interested in advancing ...
To accelerate Parkinson's disease (PD) research and connect eligible participants with clinical trials, the Parkinson's Foundation announced the first major milestone of its new PD Trial Navigator ...
GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results